$250.61
+0.72%
N/A+$1.79
Healthcare
Drug Manufacturers - General
NYSE
Active Trading
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. ...
Loading analysis...
Profitability
Net MarginN/A
Operating MarginN/A
Valuation
P/E Ratio29.34x
Current RatioN/A
Efficiency
ROE26.40%
ROA8.42%
Fundamental Analysis
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Key Strengths
- Industry-leading gross margins
- Strong cash flow generation
- High R&D investment ratio
- Market leadership in AI chips
Risk Factors
- Premium valuation multiples
- Semiconductor cycle exposure
- Intense competition
- Geographic concentration
Market Cap vs Revenue & Earnings
Earnings
n/a
Revenue
n/a
Market cap
$603.27B
n/a
P/E Ratio
n/a
P/S Ratio
Earnings & Revenue
Last Reportedn/a
Earnings per share (EPS)n/a
Gross Marginn/a
Net Profit Marginn/a
Debt/Equity Ration/a
Profitability Bridge (Current vs YoY)
How gross, operating and net margins shifted versus last year.
Revenue / Net Income / FCF History (USD B)
Growth Signals
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | Flat |
| Diluted EPS | — | — | — | — | Flat |
| Free Cash Flow | — | — | — | — | Flat |
Profitability
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| Net Margin | — | 21.76% | — | — | Flat |
| Operating Margin | — | 26.58% | — | — | Flat |
| ROE | — | — | — | — | Flat |
Financial Health
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| Current Ratio | — | 1.025 | — | — | Flat |
| Quick Ratio | — | 0.773 | — | — | Flat |
| Debt / Equity | — | 0.677 | — | — | Flat |
Valuation
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| P/E | — | 28.33x | — | — | Flat |
| P/B | — | 7.30x | — | — | Flat |